Thymosin Alpha-1
Thymosin α1
A naturally occurring thymic peptide that modulates immune function. FDA-approved as Zadaxin for hepatitis B and C, and used off-label for immune support.
Typical Cost
$300-600/month (Zadaxin)
Status
Research
Peptide Profile
Thymosin Alpha-1
Mechanism of Action
Enhances T-cell differentiation and maturation. Increases NK cell activity. Modulates cytokine production. Restores immune balance in immunocompromised patients.
Common Dosages
subcutaneous
1.6mg
2x weekly · 6-12 months (hepatitis)
Benefits
Immune enhancement
Anti-viral support
T-cell modulation
FDA-approved indication
Well-tolerated
Side Effects
Injection site reactions
Rare allergic reactions
Mild flu-like symptoms
Key Research
Zadaxin hepatitis trials
FDA approval based on efficacy in hepatitis B and C
Thymosin Alpha-1 immune modulation
Enhanced T-cell function and cytokine balance
Regulatory Status
FDA-approved as Zadaxin (thymalfasin) for hepatitis B/C. Used off-label for immune modulation.
Contraindications
- ⚠Organ transplant recipients
- ⚠Pregnancy/breastfeeding
GLP-1 users with immune concerns may discuss with healthcare provider alongside SeraVia formulations.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.